Hepatitis C Treatment for People With Severe Mental Illness
Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and...
Gespeichert in:
| Veröffentlicht in: | Psychosomatics (Washington, D.C.) D.C.), 2006-03, Vol.47 (2), p.93-107 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107 |
|---|---|
| container_issue | 2 |
| container_start_page | 93 |
| container_title | Psychosomatics (Washington, D.C.) |
| container_volume | 47 |
| creator | Mistler, Lisa A. Brunette, Mary F. Marsh, Bryan J. Vidaver, Robert M. Luckoor, Ravi Rosenberg, Stanley D. |
| description | Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and HCV has been controversial. Effective antiviral treatment is available, but side effects include depression and other neuropsychiatric symptoms. This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI |
| doi_str_mv | 10.1176/appi.psy.47.2.93 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20836477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0033318206700019</els_id><sourcerecordid>1006193091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-5dc4d0fae12891fc896acebd3b78f10807a0cc0b03c1705285facd9c75a759283</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMoun7cPUkR9NY6SZom1ZMsfiysKKh4DNl0ipFuW5Puwv57s-yCIHiawzzvzMtDyCmFjFJZXJm-d1kfVlkuM5aVfIeMqMhFKhkUu2QEwHnKqWIH5DCELwAQVBT75IAWAhQwGJGbR-zN4AYXknHy5tEMc2yHpO588oJd32Dy4YbP5BWX6DF5ijvTJJOmaTGEY7JXmybgyXYekff7u7fxYzp9fpiMb6epzaUaUlHZvILaIGWqpLVVZWEszio-k6qmsYc0YC3MgFsqQTAlamOr0kphpCiZ4kfkcnO39933AsOg5y5YbBrTYrcImoHiRS5lBM__gF_dwrexm2YMeC4kZxGCDWR9F4LHWvfezY1faQp6bVWvrepoVedSM13yGDnb3l3M5lj9BrYaI3CxBUywpqm9aa0Lv5wUigqx_n294TDqWjr0OliHrcXKebSDrjr3f4sfF_iU4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220345732</pqid></control><display><type>article</type><title>Hepatitis C Treatment for People With Severe Mental Illness</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Mistler, Lisa A. ; Brunette, Mary F. ; Marsh, Bryan J. ; Vidaver, Robert M. ; Luckoor, Ravi ; Rosenberg, Stanley D.</creator><creatorcontrib>Mistler, Lisa A. ; Brunette, Mary F. ; Marsh, Bryan J. ; Vidaver, Robert M. ; Luckoor, Ravi ; Rosenberg, Stanley D.</creatorcontrib><description>Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and HCV has been controversial. Effective antiviral treatment is available, but side effects include depression and other neuropsychiatric symptoms. This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI</description><identifier>ISSN: 0033-3182</identifier><identifier>EISSN: 1545-7206</identifier><identifier>DOI: 10.1176/appi.psy.47.2.93</identifier><identifier>PMID: 16508020</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Antiviral Agents - adverse effects ; Biological and medical sciences ; Depressive Disorder, Major - chemically induced ; Depressive Disorder, Major - epidemiology ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - epidemiology ; Human viral diseases ; Humans ; Infectious diseases ; Interferons - adverse effects ; Medical sciences ; Mental Disorders - epidemiology ; Viral diseases ; Viral hepatitis</subject><ispartof>Psychosomatics (Washington, D.C.), 2006-03, Vol.47 (2), p.93-107</ispartof><rights>2011 The Academy of Psychosomatic Medicine</rights><rights>2006 INIST-CNRS</rights><rights>Copyright American Psychiatric Publishing, Inc. Mar/Apr 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-5dc4d0fae12891fc896acebd3b78f10807a0cc0b03c1705285facd9c75a759283</citedby><cites>FETCH-LOGICAL-c478t-5dc4d0fae12891fc896acebd3b78f10807a0cc0b03c1705285facd9c75a759283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/220345732?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17581552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16508020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mistler, Lisa A.</creatorcontrib><creatorcontrib>Brunette, Mary F.</creatorcontrib><creatorcontrib>Marsh, Bryan J.</creatorcontrib><creatorcontrib>Vidaver, Robert M.</creatorcontrib><creatorcontrib>Luckoor, Ravi</creatorcontrib><creatorcontrib>Rosenberg, Stanley D.</creatorcontrib><title>Hepatitis C Treatment for People With Severe Mental Illness</title><title>Psychosomatics (Washington, D.C.)</title><addtitle>Psychosomatics</addtitle><description>Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and HCV has been controversial. Effective antiviral treatment is available, but side effects include depression and other neuropsychiatric symptoms. This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI</description><subject>Antiviral Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Depressive Disorder, Major - chemically induced</subject><subject>Depressive Disorder, Major - epidemiology</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - epidemiology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Interferons - adverse effects</subject><subject>Medical sciences</subject><subject>Mental Disorders - epidemiology</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><issn>0033-3182</issn><issn>1545-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kE1LxDAQhoMoun7cPUkR9NY6SZom1ZMsfiysKKh4DNl0ipFuW5Puwv57s-yCIHiawzzvzMtDyCmFjFJZXJm-d1kfVlkuM5aVfIeMqMhFKhkUu2QEwHnKqWIH5DCELwAQVBT75IAWAhQwGJGbR-zN4AYXknHy5tEMc2yHpO588oJd32Dy4YbP5BWX6DF5ijvTJJOmaTGEY7JXmybgyXYekff7u7fxYzp9fpiMb6epzaUaUlHZvILaIGWqpLVVZWEszio-k6qmsYc0YC3MgFsqQTAlamOr0kphpCiZ4kfkcnO39933AsOg5y5YbBrTYrcImoHiRS5lBM__gF_dwrexm2YMeC4kZxGCDWR9F4LHWvfezY1faQp6bVWvrepoVedSM13yGDnb3l3M5lj9BrYaI3CxBUywpqm9aa0Lv5wUigqx_n294TDqWjr0OliHrcXKebSDrjr3f4sfF_iU4A</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Mistler, Lisa A.</creator><creator>Brunette, Mary F.</creator><creator>Marsh, Bryan J.</creator><creator>Vidaver, Robert M.</creator><creator>Luckoor, Ravi</creator><creator>Rosenberg, Stanley D.</creator><general>Elsevier Inc</general><general>American Psychiatric Press</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>200603</creationdate><title>Hepatitis C Treatment for People With Severe Mental Illness</title><author>Mistler, Lisa A. ; Brunette, Mary F. ; Marsh, Bryan J. ; Vidaver, Robert M. ; Luckoor, Ravi ; Rosenberg, Stanley D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-5dc4d0fae12891fc896acebd3b78f10807a0cc0b03c1705285facd9c75a759283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antiviral Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Depressive Disorder, Major - chemically induced</topic><topic>Depressive Disorder, Major - epidemiology</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - epidemiology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Interferons - adverse effects</topic><topic>Medical sciences</topic><topic>Mental Disorders - epidemiology</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><toplevel>online_resources</toplevel><creatorcontrib>Mistler, Lisa A.</creatorcontrib><creatorcontrib>Brunette, Mary F.</creatorcontrib><creatorcontrib>Marsh, Bryan J.</creatorcontrib><creatorcontrib>Vidaver, Robert M.</creatorcontrib><creatorcontrib>Luckoor, Ravi</creatorcontrib><creatorcontrib>Rosenberg, Stanley D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Psychosomatics (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mistler, Lisa A.</au><au>Brunette, Mary F.</au><au>Marsh, Bryan J.</au><au>Vidaver, Robert M.</au><au>Luckoor, Ravi</au><au>Rosenberg, Stanley D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis C Treatment for People With Severe Mental Illness</atitle><jtitle>Psychosomatics (Washington, D.C.)</jtitle><addtitle>Psychosomatics</addtitle><date>2006-03</date><risdate>2006</risdate><volume>47</volume><issue>2</issue><spage>93</spage><epage>107</epage><pages>93-107</pages><issn>0033-3182</issn><eissn>1545-7206</eissn><abstract>Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and HCV has been controversial. Effective antiviral treatment is available, but side effects include depression and other neuropsychiatric symptoms. This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>16508020</pmid><doi>10.1176/appi.psy.47.2.93</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-3182 |
| ispartof | Psychosomatics (Washington, D.C.), 2006-03, Vol.47 (2), p.93-107 |
| issn | 0033-3182 1545-7206 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_20836477 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Antiviral Agents - adverse effects Biological and medical sciences Depressive Disorder, Major - chemically induced Depressive Disorder, Major - epidemiology Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - epidemiology Human viral diseases Humans Infectious diseases Interferons - adverse effects Medical sciences Mental Disorders - epidemiology Viral diseases Viral hepatitis |
| title | Hepatitis C Treatment for People With Severe Mental Illness |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20C%20Treatment%20for%20People%20With%20Severe%20Mental%20Illness&rft.jtitle=Psychosomatics%20(Washington,%20D.C.)&rft.au=Mistler,%20Lisa%20A.&rft.date=2006-03&rft.volume=47&rft.issue=2&rft.spage=93&rft.epage=107&rft.pages=93-107&rft.issn=0033-3182&rft.eissn=1545-7206&rft_id=info:doi/10.1176/appi.psy.47.2.93&rft_dat=%3Cproquest_cross%3E1006193091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220345732&rft_id=info:pmid/16508020&rft_els_id=S0033318206700019&rfr_iscdi=true |